The clinical importance of the neonatal Fc receptor in RPE.

The clinical importance of the neonatal Fc receptor in RPE. - FcRn in the RPE.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32041

Enrollment

200

Registered

2008-09-18

Start date

2009-06-18

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

age related macular degeneration

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age >= 18 years - Informed consent - Age related macular degeneration (ARMD group) or no ARMD (control group)

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Confirmation of the role of FcRn in metabolism and transport of vitreous IgG and monoclonals (Avastin, Lucentis), frequency of FcRn mutations and polymorphisms.	—

Countries

Netherlands

Outcome results